Home/Filings/4/0000899243-19-026603
4//SEC Filing

KPCB XIV Founders Fund, LLC 4

Accession 0000899243-19-026603

CIK 0001720725other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 5:59 PM ET

Size

11.5 KB

Accession

0000899243-19-026603

Insider Transaction Report

Form 4
Period: 2019-11-04
Transactions
  • Conversion

    Common Stock, par value $0.001 per share

    2019-11-04+45,529367,987 total
  • Conversion

    Series A Convertible Preferred Stock

    2019-11-0445,5290 total
    Common Stock, par value $0.001 per share (45,529 underlying)
Transactions
  • Conversion

    Common Stock, par value $0.001 per share

    2019-11-04+45,529367,987 total
  • Conversion

    Series A Convertible Preferred Stock

    2019-11-0445,5290 total
    Common Stock, par value $0.001 per share (45,529 underlying)
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2019-11-0445,5290 total
    Common Stock, par value $0.001 per share (45,529 underlying)
  • Conversion

    Common Stock, par value $0.001 per share

    2019-11-04+45,529367,987 total
Footnotes (3)
  • [F1]These shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.
  • [F2]Consists of 339,284 shares of common stock held by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV") and 28,703 shares of common stock held by KPCB XIV Founders Fund, LLC ("KPCB XIV FF"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the accounts of such entities. The managing member of KPCB XIV and KPCB XIV FF is KPCB XIV Associates, LLC ("KPCB XIV Associates"). Brook Byers, L. John Doerr, William Gordon and Theodore Schlein, the managing members of KPCB XIV Associates, may be deemed to have shared voting and dispositive power over such shares.
  • [F3]Consists of 41,978 shares of Series A Convertible Preferred Stock held by KPCB XIV and 3,551 shares of Series A Convertible Preferred Stock held by KPCB XIV FF. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the accounts of such entities. The managing member of KPCB XIV and KPCB XIV FF is KPCB XIV Associates. Brook Byers, L. John Doerr, William Gordon and Theodore Schlein, the managing members of KPCB XIV Associates, may be deemed to have shared voting and dispositive power over such shares.

Issuer

Oyster Point Pharma, Inc.

CIK 0001720725

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001546197

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:59 PM ET
Size
11.5 KB